Skip to main content

Table 4 Complications between AML and ALL

From: Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

Group

aGVHD

Grade II-IVaGVHD

cGVHD

IPFD

Hemorrhagic cystitis

EBV infection

CMV infection

AML (n, %)

23 (39)

6 (10.2)

12 (20.3)

17 (28.8)

15 (25.4)

9 (15.3)

22 (37.3)

ALL (n, %)

21 (40.4)

8 (15.4)

13 (25)

18 (34.6)

18 (34.6)

18 (34.6)

26 (50)

P

1

0.568

0.651

0.545

0.307

0.026

0.186

  1. GVHD graft-versus-host disease, IPFD invasive pulmonary fungal disease, EBV Epstein–Barr virus, CMV cytomegalovirus